Joint Corp (NASDAQ:JYNT) gapped up before the market opened on Monday . The stock had previously closed at $2.36, but opened at $2.40. Joint Corp shares last traded at $2.71, with a volume of 95,987 shares.

A number of equities research analysts have recently weighed in on JYNT shares. Maxim Group cut their price target on Joint Corp from $8.00 to $5.00 and set a “buy” rating for the company in a research note on Friday, July 1st. Zacks Investment Research raised Joint Corp from a “sell” rating to a “hold” rating in a research note on Tuesday, May 17th. Finally, Feltl & Co. lowered Joint Corp from a “strong-buy” rating to a “buy” rating in a report on Friday, June 24th.

The company’s market cap is $35.63 million. The company’s 50-day moving average price is $2.27 and its 200 day moving average price is $3.01.

Joint Corp (NASDAQ:JYNT) last released its quarterly earnings results on Thursday, August 11th. The company reported ($0.26) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.27) by $0.01. The company earned $5 million during the quarter, compared to the consensus estimate of $3.40 million. On average, equities research analysts expect that Joint Corp will post ($0.97) earnings per share for the current year.

In related news, major shareholder Glenhill Advisors Llc purchased 80,069 shares of the firm’s stock in a transaction that occurred on Friday, July 1st. The stock was bought at an average cost of $1.97 per share, with a total value of $157,735.93. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.